Gemcitabine: all 1,575 studies that test it

Page 4 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.

• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerTerminatedNCT02047500Phase 1Results posted
• Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the PancreasCompletedNCT02037230Phase 1/2Results posted
• Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic CancerCompletedNCT02017015Phase 2Results posted
• A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial CancerCompletedNCT02006667Phase 2Results posted
• Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By SurgeryTerminatedNCT01958580Not applicableResults posted
• A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01951157Phase 2Results posted
• Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 StudyTerminatedNCT01949870Phase 1Results posted
• Gemcitabine Pharmacokinetics After Preoperative Chemoradiation TherapyTerminatedNCT01938716Not applicableResults posted
• Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder CancerCompletedNCT01938573Phase 1/2Results posted
• Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerTerminatedNCT01916109Phase 2Results posted
• Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic CancerTerminatedNCT01897454Phase 2Results posted
• Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDACompletedNCT01893801Phase 1/2Results posted
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)CompletedNCT01881230Phase 2/3Results posted
• Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced SarcomaCompletedNCT01879085Phase 1/2Results posted
• Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid TumorsCompletedNCT01862328Phase 1Results posted
• Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung CancerTerminatedNCT01860040Phase 2Results posted
• Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic CancerTerminatedNCT01851174Phase 2Results posted
• A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic AdenocarcinomaCompletedNCT01839799Phase 2Results posted
• A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic CancerCompletedNCT01833546Phase 1Results posted
• First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract CarcinomaCompletedNCT01828034Phase 1/2Results posted
• Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma PatientsCompletedNCT01822886Phase 2Results posted
• A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung CancerCompletedNCT01788566Phase 2Results posted
• Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refractory Hodgkin LymphomaCompletedNCT01780662Phase 1/2Results posted
• GTX-RT in Borderline Resectable Pancreatic CancerTerminatedNCT01754623Phase 2Results posted
• CHOEP + High Dose Therapy + Auto SCT for T-Cell LymphomaTerminatedNCT01746173Phase 2Results posted
• Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")CompletedNCT01726582Phase 2Results posted
• Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin LymphomaCompletedNCT01701986Phase 1/2Results posted
• Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)CompletedNCT01684878Phase 3Results posted
• A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01663272Phase 1Results posted
• A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary CancersCompletedNCT01661114Phase 2Results posted
• Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal AdenocarcinomaTerminatedNCT01639131Phase 2Results posted
• Allogeneic Stem Cell Transplant for CLLTerminatedNCT01629511Phase 1/2Results posted
• Gemcitabine and Pazopanib in Chemotherapy Naïve Patients With Advanced/Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based ChemotherapyTerminatedNCT01622660Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder CancerTerminatedNCT01611662Phase 2Results posted
• A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-CisplatinCompletedNCT01606748Phase 2Results posted
• Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the VulvaStatus unknownNCT01595061Phase 2Results posted
• A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue SarcomaCompletedNCT01593748Phase 2Results posted
• Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder CancerCompletedNCT01589094Phase 2Results posted
• Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT01585805Phase 2Results posted
• Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the PancreasCompletedNCT01560949Phase 2Results posted
• Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT01535924Phase 1/2Results posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Chemotherapy and Radiation Therapy for Pancreatic CancerCompletedNCT01534637Phase 2Results posted
• Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by SurgeryTerminatedNCT01533207Phase 3Results posted
• Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue SarcomaCompletedNCT01532687Phase 2Results posted
• First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial CarcinomaCompletedNCT01524991Phase 2Results posted
• Clinical Trial of High-dose Vitamin C for Advanced Pancreatic CancerTerminatedNCT01515046Phase 2Results posted
• Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT01473940Phase 1Results posted
• Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic CancerCompletedNCT01459614Phase 2Results posted
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)CompletedNCT01454102Phase 1Results posted
• Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)CompletedNCT01443078Phase 2Results posted
• GSK1120212 Rollover StudyTerminatedNCT01376310Phase 2Results posted
• Gemcitabine/Capecitabine Followed by SBRT in Pancreatic AdenocarcinomaCompletedNCT01360593Phase 2Results posted
• A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid TumorsCompletedNCT01341457Phase 1Results posted
• Gemcitabine and CT-011 for Resected Pancreatic CancerTerminatedNCT01313416Phase 2Results posted
• Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerCompletedNCT01308840Phase 2Results posted
• Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialCompletedNCT01294358Phase 1Results posted
• A Safety Study in Participants With Advanced Solid TumorsTerminatedNCT01284335Phase 1Results posted
• Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial CarcinomaCompletedNCT01261728Phase 2Results posted
• A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemo With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the PancreasTerminatedNCT01240304Phase 2Results posted
• High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk MyelomaCompletedNCT01237951Phase 2Results posted
• A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast CancerCompletedNCT01201265Phase 2Results posted
• High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's DiseaseCompletedNCT01200329Phase 2Results posted
• Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic CancerCompletedNCT01195415Phase 2Results posted
• Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment DecisionTerminatedNCT01188109Phase 2Results posted
• Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By SurgeryCompletedNCT01164228Phase 2Results posted
• A Study of Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01160744Phase 2Results posted
• Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver TransplantationTerminatedNCT01151761Phase 2Results posted
• Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic AdenocarcinomaCompletedNCT01146054Phase 2Results posted
• Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the PancreasCompletedNCT01128296Phase 1/2Results posted
• Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasCompletedNCT01088815Phase 2Results posted
• Gemcitabine and Pazopanib in Metastatic Pancreatic CancerTerminatedNCT01080248Phase 2Results posted
• Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's LymphomaCompletedNCT01055496Phase 1Results posted
• A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile DuctsCompletedNCT01007552Phase 2Results posted
• Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid TumorTerminatedNCT01001221Phase 1/2Results posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic CholangiocarcinomaTerminatedNCT00983541Phase 2Results posted
• Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00970684Phase 2Results posted
• A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract CancerTerminatedNCT00955721Phase 1/2Results posted
• Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract AdenocarcinomaCompletedNCT00948935Phase 2Results posted
• High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell TumorsCompletedNCT00936936Phase 2Results posted
• Gleevec and Gemzar in Patients With Epithelial Ovarian CancerCompletedNCT00928642Phase 2Results posted
• A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung CancerTerminatedNCT00924209Phase 2Results posted
• Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic TherapyCompletedNCT00919061Phase 2Results posted
• Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian CancerTerminatedNCT00910000Phase 1/2Results posted
• Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast CancerCompletedNCT00894504Phase 2Results posted
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesCompletedNCT00887809Phase 2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With GemzarCompletedNCT00869258Phase 2Results posted
• GTX Regimen for Biliary CancersTerminatedNCT00868998Phase 2Results posted
• Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
• Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin LymphomaCompletedNCT00863369Phase 1/2Results posted
• Alimta Plus Gemcitabine for Advanced SarcomaCompletedNCT00860015Phase 2Results posted
• Eloxatin® Plus Gemcitabine Chemotherapy for MesotheliomaCompletedNCT00859469Phase 2Results posted
• Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCCTerminatedNCT00859339Phase 2Results posted
• Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerCompletedNCT00847015Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerCompletedNCT00846027Phase 2Results posted
• Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
• Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the PancreasCompletedNCT00837031Phase 2Results posted
• Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminatedNCT00833859Phase 2Results posted

← Gemcitabine overview